Cancer-Fighting virus tested in Tough-to-Treat blood cancer
NCT ID NCT05514990
Summary
This study is testing whether adding a modified virus (pelareorep) to a combination of standard chemotherapy and immunotherapy drugs is safe and more effective for people with multiple myeloma that has come back or stopped responding to treatment. The goal is to see if the virus can help the immune system better attack the cancer cells. It is for patients who have already tried at least three other types of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PLASMA CELL MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Los Angeles County-USC Medical Center
Los Angeles, California, 90033, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.